Professor David Price
Chair of Primary Care Respiratory Med
- 51cg
-
- Email Address
- d.price@abdn.ac.uk
- Telephone Number
- +44 (0)1224 437237
- School/Department
- School of Medicine, Medical Sciences and Nutrition
- Publications
-
Page 23 of 97 Results 221 to 230 of 964
Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma
European Respiratory Society (ERS) International Congress., 2814Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Burden of severe asthma by biologic use and eligibility: an analysis of the International Severe Asthma Registry
European Respiratory Society (ERS) International Congress., 2143Contributions to Journals: Abstracts- [ONLINE] DOI:
Carbon footprint of inhalers in respiratory treatment: SABA CARBON International
European Respiratory Society (ERS) International Congress., 2901Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Characterising the impact of sex on severe asthma (SA) in the UK Severe Asthma Registry (UKSAR)
European Respiratory Society (ERS) International Congress., 308Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients
European Respiratory Society (ERS) International Congress., pp. 1552Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Mortality outcomes associated with oral corticosteroid use in patients with COPD
European Respiratory Society (ERS) International Congress., 1819Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]
Over-the-counter (OTC) short-acting β2-agonist (SABA) purchase and asthma outcomes in SABINA III
European Respiratory Society (ERS) International Congress., 3434Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Patient-reported barriers to accepting a technological adherence package in the MAGNIFY trial
European Respiratory Society (ERS) International Congress., 3402Contributions to Journals: Abstracts- [ONLINE]
- [ONLINE] DOI:
- [OPEN ACCESS]
Persistent reductions in OCS use in patients with severe, OCS dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study
World Allergy Congress 2022, pp. 383Contributions to Journals: Abstracts- [ONLINE]
Real-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patients
European Respiratory Society (ERS) International Congress., 3305Contributions to Journals: Abstracts- [ONLINE] DOI:
- [OPEN ACCESS]